Cyndeo Wealth Partners’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTXH
Cyndeo Wealth Partners's FTXH Position: Q3 2026 in Review
Cyndeo Wealth Partners opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 36,743 shares worth $1.52M. The stake represents 0.07% of the portfolio and ranks #223 among its holdings.
70 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.
- Cyndeo Wealth Partners held 36,743 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.52M as of Q3 2026.
- First Trust Nasdaq Pharmaceuticals ETF was a new Cyndeo Wealth Partners position in Q3 2026.
- First Trust Nasdaq Pharmaceuticals ETF made up 0.07% of Cyndeo Wealth Partners's portfolio in Q3 2026, its #223 holding.
- 70 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.
Based on Cyndeo Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.